ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,212Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 2888

$1.88M Total Retail Price of All Prescriptions

Rank: 34 out of 2888

835 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 835 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 18,252 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 908 499 1 2
LEVOTHYROXINE SODIUM 898 644 2 1
AMLODIPINE BESYLATE 886 631 3 5
LISINOPRIL 768 517 4 3
FUROSEMIDE 666 495 5 6
METOPROLOL TARTRATE 645 447 6 10
TRAMADOL HCL 598 478 7 16
OMEPRAZOLE 578 335 8 7
QUETIAPINE FUMARATE 449 353 9 66
HYDROCODONE-ACETAMINOPHEN 446 288 S3 10 4
METFORMIN HCL 369 224 11 8
LIDODERM 336 279 12 105
GABAPENTIN 333 270 13 13
WARFARIN SODIUM 333 271 13 22
NAMENDA 330 330 15 34
POLYETHYLENE GLYCOL 3350 290 142 16 93
ZOLPIDEM TARTRATE 285 186 17 17
CLONIDINE HCL 267 155 18 39
ATORVASTATIN CALCIUM 261 139 19 9
POTASSIUM CHLORIDE 258 218 20 14
DONEPEZIL HCL 258 258 20 26
MIRTAZAPINE 238 198 22 54
TRAZODONE HCL 233 177 23 43
LANTUS 227 174 24 45
DIOVAN 223 165 25 35
LOSARTAN POTASSIUM 219 180 26 18
SERTRALINE HCL 218 173 27 27
RANITIDINE HCL 212 162 28 56
PRAVASTATIN SODIUM 209 122 29 12
NEXIUM 196 118 30 19
METOPROLOL SUCCINATE 192 138 31 11
CYMBALTA 192 144 31 44
SEROQUEL 189 153 33 143
TAMSULOSIN HCL 182 126 34 29
CARVEDILOL 181 153 35 21
LYRICA 181 138 35 69
LEVETIRACETAM 172 98 37 103
PREDNISONE 166 117 38 42
LACTULOSE 164 119 39 111
ATENOLOL 155 97 40 25
KLOR-CON M20 154 90 41 90
CLOPIDOGREL 148 118 42 30
RISPERIDONE 148 101 42 72
AZITHROMYCIN 147 87 44 38
ESCITALOPRAM OXALATE 140 103 45 62
FENOFIBRATE 135 66 46 65
CRESTOR 135 59 46 20
GLIPIZIDE 134 116 48 50
NOVOLOG 134 91 48 114
PROMETHAZINE HCL 133 74 R 50 96
NOVOLIN R 131 118 51 109
EXELON 130 129 52 106
LEVOFLOXACIN 127 102 53 57
NIFEDIPINE ER 122 72 54 76
CARBIDOPA-LEVODOPA 122 112 54 113
BENZTROPINE MESYLATE 122 66 R 54 191
NOVOLOG FLEXPEN 121 77 57 171
BACLOFEN 120 30 58 121
KLOR-CON M10 118 98 59 118
ALENDRONATE SODIUM 115 67 60 23
DIGOXIN 111 92 61 55
SANTYL 108 102 62 210
JANUVIA 108 81 62 48
PANTOPRAZOLE SODIUM 105 63 64 33
ISOSORBIDE MONONITRATE ER 103 93 65 51
MELOXICAM 103 81 65 31
FAMOTIDINE 103 64 65 75
OXYBUTYNIN CHLORIDE ER 103 66 65 132
CITALOPRAM HBR 103 47 65 24
DOXYCYCLINE HYCLATE 99 42 70 123
ADVAIR DISKUS 99 55 70 60
ALLOPURINOL 96 79 72 37
PHENYTOIN SODIUM EXTENDED 95 58 73 128
PLAVIX 94 79 74 40
HYDROCHLOROTHIAZIDE 90 67 75 15
SYMBICORT 90 40 75 142
ALBUTEROL SULFATE 90 69 75 134
TRICOR 89 46 78 91
GLIPIZIDE ER 87 72 79 107
TORSEMIDE 87 84 79 158
SODIUM CHLORIDE 84 83 81 371
HYDRALAZINE HCL 83 59 82 59
MUPIROCIN 81 54 83 184
FELODIPINE ER 80 80 84 175
HYDROXYZINE HCL 77 67 R 85 174
CLOTRIMAZOLE-BETAMETHASONE 76 41 86 136
FLUTICASONE PROPIONATE 75 37 87 32
TRIAMCINOLONE ACETONIDE 74 54 88 145
OLANZAPINE 74 37 88 137
METOLAZONE 73 47 90 215
DOXAZOSIN MESYLATE 72 64 91 94
FLUOXETINE HCL 70 49 92 83
NAPROXEN 68 32 93 80
AMIODARONE HCL 68 56 93 167
DIVALPROEX SODIUM 67 42 95 100
ENALAPRIL MALEATE 67 56 95 49
LOSARTAN-HYDROCHLOROTHIAZIDE 67 56 95 46
VALPROIC ACID 66 64 98 278
VESICARE 66 46 98 154
FINASTERIDE 65 39 100 102
GLUCAGEN 65 58 100 288
MEGESTROL ACETATE 64 59 R 102 140
CIPROFLOXACIN HCL 63 48 103 47
AMOXICILLIN 62 27 104 117
PROAIR HFA 62 26 104 71
PAROXETINE HCL 61 45 106 84
SPIRIVA 60 42 107 79
SPIRONOLACTONE 60 53 107 70
OXYBUTYNIN CHLORIDE 59 0 109 124
LIPITOR 59 38 109 78
HALOPERIDOL 59 29 109 282
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 33 112 28
LEVEMIR 58 31 112 135
DILTIAZEM 24HR CD 58 57 112 146
OXCARBAZEPINE 57 12 115 342
AMLODIPINE BESYLATE-BENAZEPRIL 57 34 115 67
CEPHALEXIN 57 31 115 119
HUMALOG 57 47 115 166
IBUPROFEN 56 21 119 87
DIVALPROEX SODIUM ER 56 14 119 185
LANTUS SOLOSTAR 56 42 119 92
ACTOS 53 38 122 108
NYSTATIN 53 32 122 178
ROPINIROLE HCL 53 51 122 115
PROPRANOLOL HCL 52 26 125 164
GEMFIBROZIL 52 22 125 98
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 38 125 88
LEVEMIR FLEXPEN 51 27 128 156
BYSTOLIC 51 21 128 99
IPRATROPIUM-ALBUTEROL 50 43 130 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.